High-dose-rate brachytherapy as part of a multidisciplinary treatment of nasopharyngeal lymphoepithelioma in childhood

Cancer

Volumn 104, Issue 3, 2005, Pages 525-531

  Nakamura, Ricardo Akiyoshi ^a   Novaes, Paulo Eduardo Ribeiro Dos Santos ^a   Antoneli, Célia Beatriz Gianotti ^a   Fogaroli, Ricardo César ^a   Pellizzon, Antonio Cássio Assis ^a   Ferrigno, Robson ^a   Maia, Maria Aparecida Conte ^a   Salvajoli, João Victor ^a   Pereira, Adelino José ^a   Nishimoto, Inês Nobuko ^a  

^a A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

Brachytherapy; Chemotherapy; Childhood; Nasopharyngeal carcinoma; Radiotherapy

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; VINCRISTINE;

ADJUVANT CHEMOTHERAPY; ADOLESCENT; ADULT; ANEMIA; ARTICLE; BEAM THERAPY; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER STAGING; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; LEUKOPENIA; LOCAL ANESTHESIA; LYMPH NODE METASTASIS; LYMPHOEPITHELIOMA; MALE; NASOPHARYNX CARCINOMA; OUTPATIENT CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; RADIATION INJURY; SCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; CHILD; CISPLATIN; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NASOPHARYNGEAL NEOPLASMS; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROGNOSIS; QUALITY OF LIFE; RETROSPECTIVE STUDIES; SURVIVAL RATE; VINCRISTINE;

EID: 22544475571     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21207     Document Type: Article

References (45)

1. Gastpar H, Wilmes E, Wolf H. Epidemiologic, etiologic and immunologic aspects of nasopharyngeal carcinoma. J Med. 1981;12:257-284.
2. Miller D. The etiology of nasopharyngeal cancer and its management. Otolaryngol Clin North Am. 1980;13:467-475.
3. Henderson BE, Louie E, Jing JSH, Buell P, Gardner M. Risk factors associated with nasopharyngeal carcinoma. N Engl J Med. 1976;295:1101-1106.
4. Yu MC, Ho JHC, Lai SH, Henderson BE. Cantonese-style salted fish as a cause of nasopharyngeal carcinoma: report of a case-control study in Hong Kong. Cancer Res. 1986;46:956-961.
5. Old LJ, Boyse EA, Oettgeri HF, et al. Precipitating antibody in human serum to an antigen present in cultured Burkitt's lymphoma cells. Proc Natl Acad Sci USA. 1966;56:1692-1698.
6. zur Hausen H, Schulte-Holthausen H, Klein G, et al. Epstein-Barr virus DNA in biopsies of Burkitt tumors and anaplastic carcinoma of the nasopharynx. Nature. 1970;228:1056-1058.
7. Papavasiliou C, Pavlatou M, Pappas J. Nasopharyngeal cancer in patients under the age of thirty years. Cancer. 1977;40:2312-2316.
8. Shanmugaratnam K, Chan SH, de-The G, et al. Histopathology of nasopharyngeal carcinoma: correlations with epidemiology, survival rates and other biological characteristics. Cancer. 1979;44:1029-1044.
9. Henle W, Henle G. Evidence for an etiologic relation of the Epstein-Barr virus to human malignancies. Laryngoscope. 1977;87(4 Pt 1):467-473.
10. Pao WJ, Hustu HO, Douglass EC, Beckford NS, Kun LE. Pediatric nasopharyngeal carcinoma: long term follow-up of 29 patients. Int J Radiat Oncol Biol Phys. 1989;17:299-305.
11. Ingersoll L, Woo Sy, Donaldson S, et al. Nasopharyngeal carcinoma in the young: a combined M. D. Anderson and Stanford experience. Int J Radiat Oncol Biol Phys. 1990;19:881-887.
12. Fernandez CH, Cangir A, Saaman NA, Rivera R. Nasopharyngeal carcinoma in children. Cancer. 1976;37:2787-2791.
13. Jenkin RDT, Anderson JR, Jereb B, et al. Nasopharyngeal carcinoma-a retrospective review of patients less than thirty years of age: a report of Children's Cancer Study Group. Cancer. 1981;47:360-366.
14. Schmincke A. Veber lymphoepitheliale geschwulste beiter. Pathol Anat. 1921;58:161-170.
15. Wolden SL, Stenherz PG, Kraus DH, et al. Improved long term survival with combined modality therapy for pediatric nasopharynx cancer. Int J Radiat Oncol Biol Phys. 2000;46:859-864.
16. American Joint Committee on Cancer. Cancer staging handbook. Pharynx cancer. In: Greene FL, Page DL, Fleming ID, et al., editors. AJCC cancer staging manual, 6th ed. New York: Springer-Verlag, 2002:47.
17. Novaes PERS, Ferrigno R, Pellizzon ACA, et al. High dose rate brachytherapy with rigid catheters in the treatment of nasopharyngeal carcinoma: original technique and results. Int J Radiat Oncol Biol Phys, 1996;36(Suppl 1):S337.
18. Harrison LB, Sessions RB, Pass DE, Armstrong JG, Hunt M, Spiro RH. Nasopharyngeal brachytherapy with access via a transpalatal flap. Am J Surg. 1992;164:173-175.
19. Radiation Oncology Therapy Group. Acute radiation morbidity scoring criteria. Available at URL: http://www.rtog.org/members/toxicity/acute.html [accessed October 1, 2004].
20. Eastern Cooperative Oncology Group. ECOG common toxicity criteria. Available at URL: http://www.ecog.org/general/ctc.pdf [accessed October 1, 2004].
21. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
22. Huang TB. Cancer of the nasopharynx in childhood. Cancer. 1990;66:968-971.
23. Arush MW, Stein ME, Rosenblatt E, Lavie R, Kuten A. Advanced nasopharyngeal carcinoma in the young: the Northern Israel Oncology Center experience, 1973-1991. Pediatr Hematol Oncol. 1995;12:271-276.
24. Serin M, Erkal HS, Elhan AH, Cakmak A. Nasopharyngeal carcinoma in childhood and adolescence. Med Pediatr Oncol. 1998;31:498-505.
25. Martin WD, Shah KJ. Carcinoma of the nasopharynx in young patients. Int J Radiat Oncol Biol Phys. 1994;28:991-999.
26. 45. Uzel O, Yoruk SO, Sahinler I, Turkan S, Okkan S. Nasopharyngeal carcinoma in childhood: long-term results of 32 patients. Radiother Oncol. 2001;58:137-141.
27. Deutsch M, Mercado R Jr., Parson JA. Cancer of the nasopharynx in children. Cancer. 1978;41:1128-1133.
28. Berry MP, Smith CR, Brown TC, Jenkin RD, Rider WD. Nasopharyngeal carcinoma in the young. Int J Radiat Oncol Biol Phys. 1980;6:415-421.
29. Decker DA, Drelichman A, Al-Sarraf M, Crissman J, Reed ML. Chemotherapy for nasopharyngeal carcinoma. A ten-year experience. Cancer. 1983;52:602-605.
30. Dimery IW, Legha SS, Peters LJ, Goepfert H, Oswald MJ. Adjuvant chemotherapy for advanced nasopharyngeal carcinoma. Cancer. 1987;60:943-949.
31. Ervin TJ, Clark JR, Weichselbaum RR, et al. An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck. J Clin Oncol. 1987;5:10-20.
32. Huang SC, Lui LT, Lynn TC. Nasopharyngeal cancer: study III. A review of 1206 patients treated with combined modalities. Int J Radiat Oncol Biol Phys. 1985;11:1789-1793.
33. Khoury GG, Paterson IC. Nasopharyngeal carcinoma: a review of cases treated by radiotherapy and chemotherapy. Clin Radiol. 1987;38:17-20.
34. Tannock I, Payne D, Cummings B, Hewitt K, Panzarella T. Sequential chemotherapy and radiation for nasopharyngeal cancer: absence of long-term benefit despite a high rate of tumor response to chemotherapy. J Clin Oncol. 1987;5:629-634.
35. Lobo-Sanahuja F, Garcia I, Carranza A, Camacho A. Treatment and outcome of undifferentiated carcinoma of the nasopharynx in childhood: a 13-year experience. Med Pediatr Oncol. 1986;14:6-11.
36. Roper HP, Essex-Cater A, Marsden HB, Dixon PF, Campbell RH. Nasopharyngeal carcinoma in children. Pediatr Hematol Oncol. 1986;3:143-152.
37. Gasparini M, Lombardi F, Rottoli L, Ballerini E, Morandi F. Combined radiotherapy and chemotherapy in Stage T3 and T4 nasopharyngeal carcinoma in children. J Clin Oncol. 1988;6:491-494.
38. Barjaktarevic ZD, Golubicic IV. Undifferentiated nasopharyngeal carcinoma in children: a report of four cases. J Chemother. 1995;7:249-252.
39. Werner-Wasik M, Winkler P, Uri A, Goldwein J. Nasopharyngeal carcinoma in children. Med Pediatr Oncol. 1996;26:352-358.
40. Strojan P, Benedik MD, Kragelj B, Jereb B. Combined radiation and chemotherapy for advanced undifferentiated nasopharyngeal carcinoma in children. Med Pediatr Oncol. 1997;28:366-369.
41. Mertens R, Granzen B, Lassay L, Gademann G, Hess CF, Heimann G. Nasopharyngeal carcinoma in childhood and adolescence: concept and preliminary results of the cooperative GPOH study NPC-91. Gesellschaft fur Padiatrische Onkologie und Hamatologie. Cancer. 1997;80:951-959.
42. Ghim TT, Briones M, Mason P, et al. Effective adjuvant chemotherapy for advanced nasopharyngeal carcinoma in children: a final update of a long-term prospective study in a single institution. J Pediatr Hematol Oncol. 1998;20:131-135.
43. Zubizarreta PA, D'Antonio G, Raslawski E, et al. Nasopharyngeal carcinoma in childhood and adolescence: a single-institution experience with combined therapy. Cancer. 2000;89:690-695.
44. Daoud J, Toumi N, Bouaziz M, et al. Nasopharyngeal carcinoma in childhood and adolescence: analysis of a series of 32 patients treated with combined chemotherapy and radiotherapy. Eur J Cancer. 2003;39:2349-2354.
45. Kim TH, McLaren J, Alvarado CS, et al. Adjuvant chemotherapy for advanced nasopharyngeal carcinoma in childhood. Cancer. 1989;63:1922-1926.